Efficiency of Immunotoxin Cytotoxicity Is Modulated by the Intracellular Itinerary

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Tortorella, Lori L ^a   Pipalia, Nina H ^a   Mukherjee, Sushmita ^a   Pastan, Ira ^b   Fitzgerald, David ^b   Maxfield, Frederick R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; FURIN; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE PROTEIN; PROTEIN TGN38; PSEUDOMONAS EXOTOXIN; PSEUDOMONAS EXOTOXIN LMB 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CELL KILLING; CELL VIABILITY; CELLULAR DISTRIBUTION; CHIMERA; CHO CELL; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY TEST; ENDOCYTOSIS; ENDOSOME; IMMUNOCYTOTOXICITY; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL SURVIVAL; CHO CELLS; CRICETINAE; EXOTOXINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FURIN; HUMANS; IMMUNOBLOTTING; IMMUNOTOXINS; MEMBRANE GLYCOPROTEINS; RECEPTORS, TRANSFERRIN;

EID: 84867295577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047320     Document Type: Article

References (38)

1. Kreitman RJ, Batra JK, Seetharam S, Chaudhary VK, FitzGerald DJ, et al. (1993) Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds. Bioconjug Chem 4: 112-120.
2. Pastan I, (2003) Immunotoxins containing Pseudomonas exotoxin A: a short history. Cancer Immunol Immunother 52: 338-341.
3. Kuhn DJ, Dou QP, (2005) The role of interleukin-2 receptor alpha in cancer. Front Biosci 10: 1462-1474.
4. Kreitman RJ, Bailon P, Chaudhary VK, FitzGerald DJ, Pastan I, (1994) Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Blood 83: 426-434.
5. Kreitman RJ, (2009) Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. BioDrugs 23: 1-13.
6. Kounnas MZ, Morris RE, Thompson MR, FitzGerald DJ, Strickland DK, et al. (1992) The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem. 267: 12420-12423.
7. Smith DC, Spooner RA, Watson PD, Murray JL, Hodge TW, et al. (2006) Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic 7: 379-393.
8. Wolf P, Elsasser-Beile U, (2009) Pseudomonas exotoxin A: from virulence factor to anti-cancer agent. Int J Med Microbiol 299: 161-176.
9. Chiron MF, Fryling CM, FitzGerald DJ, (1994) Cleavage of Pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. J Biol Chem 269: 18167-18176.
10. Inocencio NM, Moehring JM, Moehring TJ, (1994) Furin activates Pseudomonas exotoxin A by specific cleavage in vivo and in vitro. J Biol Chem 269: 31831-31835.
11. McKee ML, FitzGerald DJ, (1999) Reduction of furin-nicked Pseudomonas exotoxin A: an unfolding story. Biochemistry 38: 16507-16513.
12. Keppler-Hafkemeyer A, Brinkmann U, Pastan I, (1998) Role of caspases in immunotoxin-induced apoptosis of cancer cells. Biochemistry 37: 16934-16942.
13. Keppler-Hafkemeyer A, Kreitman RJ, Pastan I, (2000) Apoptosis induced by immunotoxins used in the treatment of hematologic malignancies. Int J Cancer 87: 86-94.
14. Bosshart H, Humphrey J, Deignan E, Davidson J, Drazba J, et al. (1994) The cytoplasmic domain mediates localization of furin to the trans-Golgi network en route to the endosomal/lysosomal system. J Cell Biol 126: 1157-1172.
15. Molloy SS, Thomas L, VanSlyke JK, Stenberg PE, Thomas G, (1994) Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. Embo J 13: 18-33.
16. Schafer W, Stroh A, Berghofer S, Seiler J, Vey M, et al. (1995) Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. Embo J 14: 2424-2435.
17. Takahashi S, Nakagawa T, Banno T, Watanabe T, Murakami K, et al. (1995) Localization of furin to the trans-Golgi network and recycling from the cell surface involves Ser and Tyr residues within the cytoplasmic domain. J Biol Chem 270: 28397-28401.
18. Bos K, Wraight C, Stanley KK, (1993) TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain. Embo J 12: 2219-2228.
19. Jones SM, Crosby JR, Salamero J, Howell KE, (1993) A cytosolic complex of p62 and rab6 associates with TGN38/41 and is involved in budding of exocytic vesicles from the trans-Golgi network. J Cell Biol 122: 775-788.
20. Reaves B, Horn M, Banting G, (1993) TGN38/41 recycles between the cell surface and the TGN: brefeldin A affects its rate of return to the TGN. Mol Biol Cell 4: 93-105.
21. Duncan JR, Kornfeld S, (1988) Intracellular movement of two mannose 6-phosphate receptors: return to the Golgi apparatus. J Cell Biol 106: 617-628.
22. Ghosh RN, Mallet WG, Soe TT, McGraw TE, Maxfield FR, (1998) An endocytosed TGN38 chimeric protein is delivered to the TGN after trafficking through the endocytic recycling compartment in CHO cells. J Cell Biol 142: 923-936.
23. Lin SX, Mallet WG, Huang AY, Maxfield FR, (2004) Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes. Mol Biol Cell 15: 721-733.
24. Mallet WG, Maxfield FR, (1999) Chimeric forms of furin and TGN38 are transported with the plasma membrane in the trans-Golgi network via distinct endosomal pathways. J Cell Biol 146: 345-359.
25. Schapiro FB, Soe TT, Mallet WG, Maxfield FR, (2004) Role of cytoplasmic domain serines in intracellular trafficking of furin. Mol Biol Cell 15: 2884-2894.
26. Dudley RA, Edwards P, Ekins RP, Finney DJ, McKenzie IG, et al. (1985) Guidelines for immunoassay data processing. Clin Chem 31: 1264-1271.
27. Khinkis LA, Levasseur L, Faessel H, Greco WR, (2003) Optimal design for estimating parameters of the 4-parameter hill model. Nonlinearity Biol Toxicol Med 1: 363-377.
28. Laurence M. Levasseur HKS, Youcef M Rustum, William R Greco, (1998) Modeling of the Time-Dependency of in Vitro Drug Cytotoxicity and Resistance. Cancer Research 58: 5749-5761.
29. Pipalia NH, Huang A, Ralph H, Rujoi M, Maxfield FR, (2006) Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells. J Lipid Res 47: 284-301.
30. Pai-Scherf LH, Villa J, Pearson D, Watson T, Liu E, et al. (1999) Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor. Clin Cancer Res 5: 2311-2315.
31. Chiron MF, Fryling CM, FitzGerald D, (1997) Furin-mediated cleavage of Pseudomonas exotoxin-derived chimeric toxins. J Biol Chem 272: 31707-31711.
32. Theuer CP, FitzGerald D, Pastan I, (1992) A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing. J Biol Chem 267: 16872-16877.
33. Weldon JE, Xiang L, Chertov O, Margulies I, Kreitman RJ, et al. (2009) A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood 113: 3792-3800.
34. Hemar A, Subtil A, Lieb M, Morelon E, Hellio R, et al. (1995) Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J Cell Biol 129: 55-64.
35. Hoessli DC, Poincelet M, Rungger-Brandle E, (1990) Isolation of high-affinity murine interleukin 2 receptors as detergent-resistant membrane complexes. Eur J Immunol 20: 1497-1503.
36. Lamaze C, Dujeancourt A, Baba T, Lo CG, Benmerah A, et al. (2001) Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell 7: 661-671.
37. Kreitman RJ, Schneider WP, Queen C, Tsudo M, Fitzgerald DJ, et al. (1992) Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor. J Immunol 149: 2810-2815.
38. NIH Website: http://assay.nih.gov/assay/index.php/Section3:Determination_of_EC50-IC50.Accessed 2012 September 16.